Based on the findings obtained on growth inhibition following treatment with 1,600 ng/ml leptin, cell signaling and cell cycle changes were assessed to determine the underlying mechanisms responsible for growth inhibition in the two breast cancer cell lines. Here, LEP is linked to breast carcinoma.